Tochigi, Japan

Fumiko Okuda


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumiko Okuda: Innovator in Allergen Inactivation

Introduction

Fumiko Okuda, an accomplished inventor based in Tochigi, Japan, has made notable contributions to the field of allergen inactivation. With one registered patent, Okuda's innovative approach focuses on developing solutions that are not only effective but also safe for human use.

Latest Patents

The patent attributed to Fumiko Okuda is for an allergen inactivating agent designed to have no adverse effects on the human body. This agent effectively circumvents issues such as undesirable color development. The core component of the allergen inactivating agent is a polysaccharide derivative, featuring a cellulose ether or starch ether backbone. The molecular structure involves substituting some or all of the hydrogen atoms in the hydroxy group of the polysaccharide derivative with a specific alkylene group, providing a sophisticated solution to allergen-related problems.

Career Highlights

Fumiko Okuda's career has been marked by her work at Kao Corporation, a company known for its commitment to innovation and quality. Throughout her tenure, she has demonstrated a strong dedication to research and development, significantly influencing the company's product range and effectiveness in the market.

Collaborations

In her journey of innovation, Okuda collaborates with talented individuals such as Mami Nonomura and Kimihiko Hori. Their combined efforts enhance the research output at Kao Corporation, leading to important advancements in allergen inactivation technology.

Conclusion

Fumiko Okuda stands out as a pioneering inventor in the field of allergen inactivation. Her work not only reflects her expertise but also showcases the potential of innovative solutions that prioritize safety and efficacy. With her contributions, the future of allergen management looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…